Prostatis Group’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,047
Closed -$548K 171
2025
Q1
$548K Sell
1,047
-73
-7% -$37.3K 0.17% 90
2024
Q4
$567K Buy
1,120
+15
+1% +$8.52K 0.17% 99
2024
Q3
$646K Sell
1,105
-1,918
-63% -$1.08M 0.21% 80
2024
Q2
$1.56M Buy
3,023
+286
+10% +$140K 0.55% 49
2024
Q1
$1.35M Buy
2,737
+1,844
+206% +$937K 0.51% 51
2023
Q4
$470K Buy
893
+69
+8% +$36.8K 0.2% 85
2023
Q3
$446K Sell
824
-73,144
-99% -$36M 0.22% 70
2023
Q2
$296K Buy
73,968
+73,380
+12,480% +$35.9M 0.14% 91
2023
Q1
$286K Buy
588
+48
+9% +$23.2K 0.15% 85
2022
Q4
$286K Hold
540
0.17% 81
2022
Q3
$273K Hold
540
0.31% 46
2022
Q2
$277K Sell
540
-12
-2% -$6.03K 0.43% 29
2022
Q1
$282K Sell
552
-22
-4% -$10.6K 0.23% 62
2021
Q4
$288K Sell
574
-5
-0.9% -$2.26K 0.18% 78
2021
Q3
$226K Buy
579
+35
+6% +$14.5K 0.14% 91
2021
Q2
$218K Sell
544
-45
-8% -$17.9K 0.15% 95
2021
Q1
$219K Buy
+589
New +$204K 0.17% 88

Other funds holding UNH

Prostatis Group's UNH Position: Q2 2025 in Review

Prostatis Group sold out of UnitedHealth (UNH) in Q2 2025, closing a stake of 1,047 shares — an estimated $548K sold.

Prostatis Group first reported a position in UNH in Q1 2021 and held it in 17 quarters. The position peaked at $1.56M in Q2 2024. 3,177 funds tracked by Wall St. Rank hold UNH as of Q2 2025.

  • Prostatis Group reported no remaining UnitedHealth position as of Q2 2025 after selling out during the quarter.
  • Prostatis Group sold 1,047 UnitedHealth shares in Q2 2025, an estimated $548K.
  • Prostatis Group first reported a position in UnitedHealth in Q1 2021 and held it in 17 quarters.
  • Prostatis Group's UnitedHealth position peaked at $1.56M in Q2 2024.
  • 3,177 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2025.

Based on Prostatis Group's 13F filing for Q2 2025, filed 25 Jul 2025.